168 related articles for article (PubMed ID: 34777769)
1. Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design.
Berta D; Badaoui M; Martino SA; Buigues PJ; Pisliakov AV; Elghobashi-Meinhardt N; Wells G; Harris SA; Frezza E; Rosta E
Chem Sci; 2021 Oct; 12(40):13492-13505. PubMed ID: 34777769
[TBL] [Abstract][Full Text] [Related]
2. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.
Vivek-Ananth RP; Krishnaswamy S; Samal A
Mol Divers; 2022 Feb; 26(1):429-442. PubMed ID: 34117992
[TBL] [Abstract][Full Text] [Related]
3.
Gurung AB
Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
[TBL] [Abstract][Full Text] [Related]
4. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
[TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions.
Sommers JA; Loftus LN; Jones MP; Lee RA; Haren CE; Dumm AJ; Brosh RM
J Biol Chem; 2023 Mar; 299(3):102980. PubMed ID: 36739951
[TBL] [Abstract][Full Text] [Related]
6. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
[TBL] [Abstract][Full Text] [Related]
7. Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro.
Lu L; Peng Y; Yao H; Wang Y; Li J; Yang Y; Lin Z
Antiviral Res; 2022 Oct; 206():105389. PubMed ID: 35985407
[TBL] [Abstract][Full Text] [Related]
8. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.
Weber R; McCullagh M
J Phys Chem B; 2021 Aug; 125(31):8787-8796. PubMed ID: 34328740
[TBL] [Abstract][Full Text] [Related]
9. Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
Corona A; Madia VN; De Santis R; Manelfi C; Emmolo R; Ialongo D; Patacchini E; Messore A; Amatore D; Faggioni G; Artico M; Iaconis D; Talarico C; Di Santo R; Lista F; Costi R; Tramontano E
Antiviral Res; 2023 Sep; 217():105697. PubMed ID: 37562607
[TBL] [Abstract][Full Text] [Related]
10. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
Freidel MR; Armen RS
PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex.
Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng E; Vatandaslar H; Chait BT; Kapoor T; Darst SA; Campbell EA
bioRxiv; 2020 Jul; ():. PubMed ID: 32676607
[TBL] [Abstract][Full Text] [Related]
13. Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.
Nandi R; Bhowmik D; Srivastava R; Prakash A; Kumar D
J Biomol Struct Dyn; 2022; 40(22):12062-12074. PubMed ID: 34455933
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.
Chen J; Malone B; Llewellyn E; Grasso M; Shelton PMM; Olinares PDB; Maruthi K; Eng ET; Vatandaslar H; Chait BT; Kapoor TM; Darst SA; Campbell EA
Cell; 2020 Sep; 182(6):1560-1573.e13. PubMed ID: 32783916
[TBL] [Abstract][Full Text] [Related]
15. Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex.
Chen J; Wang Q; Malone B; Llewellyn E; Pechersky Y; Maruthi K; Eng ET; Perry JK; Campbell EA; Shaw DE; Darst SA
Nat Struct Mol Biol; 2022 Mar; 29(3):250-260. PubMed ID: 35260847
[TBL] [Abstract][Full Text] [Related]
16. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
Pitsillou E; Liang J; Hung A; Karagiannis TC
J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
[TBL] [Abstract][Full Text] [Related]
17. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations of the flexibility and inhibition of SARS-CoV-2 NSP 13 helicase.
Raubenolt BA; Islam NN; Summa CM; Rick SW
J Mol Graph Model; 2022 May; 112():108122. PubMed ID: 35021142
[TBL] [Abstract][Full Text] [Related]
20. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
